Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1114448/000137036820000003/a20012920f.htm
April 2024
January 2024
January 2024
January 2024
December 2023
December 2023
November 2023
October 2023
October 2023
October 2023
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1114448/000137036820000003/a20012920f.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Novartis Ag.
Novartis Ag's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Novartis Ag provided additional information to their SEC Filing as exhibits
Ticker: NVS
CIK: 1114448
Form Type: 20-F Annual Report
Accession Number: 0001370368-20-000003
Submitted to the SEC: Wed Jan 29 2020 8:51:01 AM EST
Accepted by the SEC: Wed Jan 29 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations